Mai Capital Management Repligen Corp Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Repligen Corp stock. As of the latest transaction made, Mai Capital Management holds 11 shares of RGEN stock, worth $1,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11Holding current value
$1,616% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
479Shares Held
54.9MCall Options Held
297KPut Options Held
343K-
Black Rock Inc. New York, NY7.57MShares$1.11 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.05 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$749 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$248 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$227 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.15B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....